 Maryam Shakiba
Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lithotripsy | 2 | 2023 | 49 | 0.840 |
Why?
| | Anesthesia, Spinal | 1 | 2023 | 13 | 0.800 |
Why?
| | Urolithiasis | 1 | 2023 | 11 | 0.790 |
Why?
| | Iran | 12 | 2024 | 44 | 0.680 |
Why?
| | Cardiovascular Diseases | 3 | 2024 | 2218 | 0.650 |
Why?
| | Obesity, Abdominal | 2 | 2018 | 48 | 0.560 |
Why?
| | Coronary Disease | 2 | 2018 | 382 | 0.550 |
Why?
| | Nutritional Status | 1 | 2021 | 353 | 0.550 |
Why?
| | Antibodies, Viral | 2 | 2021 | 687 | 0.510 |
Why?
| | Obesity | 3 | 2019 | 3149 | 0.450 |
Why?
| | Carbolines | 1 | 2012 | 35 | 0.350 |
Why?
| | Erectile Dysfunction | 1 | 2012 | 38 | 0.350 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2012 | 73 | 0.350 |
Why?
| | Prostatic Hyperplasia | 1 | 2012 | 41 | 0.340 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2012 | 62 | 0.320 |
Why?
| | Oral Health | 2 | 2022 | 139 | 0.300 |
Why?
| | Stroke | 1 | 2019 | 1287 | 0.300 |
Why?
| | Blood Pressure Determination | 1 | 2010 | 145 | 0.290 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2627 | 0.270 |
Why?
| | Hypertension | 2 | 2013 | 1280 | 0.220 |
Why?
| | Middle Aged | 17 | 2024 | 36821 | 0.220 |
Why?
| | Glucose | 2 | 2023 | 1051 | 0.200 |
Why?
| | Nephrostomy, Percutaneous | 2 | 2016 | 11 | 0.200 |
Why?
| | Humans | 29 | 2024 | 147293 | 0.200 |
Why?
| | Seroepidemiologic Studies | 2 | 2021 | 172 | 0.200 |
Why?
| | Bupivacaine | 1 | 2023 | 41 | 0.190 |
Why?
| | Kidney Calculi | 2 | 2016 | 44 | 0.190 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 2 | 2014 | 18 | 0.190 |
Why?
| | Anesthetics, Local | 1 | 2023 | 104 | 0.180 |
Why?
| | Risk Factors | 10 | 2024 | 11017 | 0.180 |
Why?
| | Heart Failure | 1 | 2016 | 2334 | 0.180 |
Why?
| | Fentanyl | 1 | 2023 | 128 | 0.180 |
Why?
| | Algorithms | 1 | 2010 | 1868 | 0.180 |
Why?
| | Cross-Sectional Studies | 4 | 2021 | 6011 | 0.180 |
Why?
| | Stomach Neoplasms | 1 | 2024 | 128 | 0.180 |
Why?
| | Male | 17 | 2023 | 73950 | 0.170 |
Why?
| | Mass Screening | 1 | 2010 | 1375 | 0.170 |
Why?
| | Ureteral Calculi | 2 | 2011 | 15 | 0.170 |
Why?
| | Publications | 1 | 2021 | 47 | 0.160 |
Why?
| | Chamomile | 1 | 2020 | 2 | 0.160 |
Why?
| | Female | 18 | 2024 | 80076 | 0.160 |
Why?
| | Health Education | 1 | 2024 | 346 | 0.160 |
Why?
| | Phytotherapy | 1 | 2020 | 74 | 0.160 |
Why?
| | Volatilization | 1 | 2019 | 45 | 0.150 |
Why?
| | Leiomyoma | 1 | 2019 | 62 | 0.150 |
Why?
| | Body Size | 1 | 2019 | 90 | 0.150 |
Why?
| | Family Characteristics | 1 | 2020 | 203 | 0.150 |
Why?
| | Uterine Neoplasms | 1 | 2019 | 98 | 0.140 |
Why?
| | Plant Extracts | 1 | 2020 | 191 | 0.140 |
Why?
| | Rhinitis | 1 | 2020 | 169 | 0.140 |
Why?
| | Double-Blind Method | 5 | 2020 | 2080 | 0.140 |
Why?
| | Quality of Life | 3 | 2024 | 3246 | 0.140 |
Why?
| | Income | 1 | 2019 | 208 | 0.140 |
Why?
| | Pain | 1 | 2023 | 794 | 0.130 |
Why?
| | Sinusitis | 1 | 2020 | 230 | 0.130 |
Why?
| | Logistic Models | 2 | 2021 | 2142 | 0.130 |
Why?
| | Public Health | 1 | 2022 | 577 | 0.120 |
Why?
| | Socioeconomic Factors | 1 | 2021 | 1342 | 0.120 |
Why?
| | Patient Positioning | 1 | 2016 | 70 | 0.110 |
Why?
| | Causality | 1 | 2016 | 129 | 0.110 |
Why?
| | Fluoroscopy | 1 | 2016 | 180 | 0.110 |
Why?
| | Supine Position | 2 | 2016 | 38 | 0.110 |
Why?
| | Prospective Studies | 6 | 2019 | 8164 | 0.110 |
Why?
| | Ultrasonography, Interventional | 1 | 2016 | 166 | 0.110 |
Why?
| | Lipoproteins, HDL | 1 | 2015 | 104 | 0.110 |
Why?
| | Kidney Transplantation | 1 | 2020 | 732 | 0.100 |
Why?
| | Urinary Retention | 1 | 2014 | 24 | 0.100 |
Why?
| | Models, Statistical | 1 | 2018 | 677 | 0.100 |
Why?
| | Mastoid | 1 | 2013 | 12 | 0.100 |
Why?
| | Otologic Surgical Procedures | 1 | 2013 | 25 | 0.100 |
Why?
| | Incidence | 2 | 2020 | 2954 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2020 | 865 | 0.100 |
Why?
| | Hypoglycemic Agents | 1 | 2023 | 1415 | 0.100 |
Why?
| | Aged | 6 | 2023 | 26514 | 0.100 |
Why?
| | Cohort Studies | 2 | 2024 | 6099 | 0.090 |
Why?
| | Survival Analysis | 1 | 2016 | 1386 | 0.090 |
Why?
| | Atherosclerosis | 1 | 2016 | 411 | 0.090 |
Why?
| | Triglycerides | 1 | 2015 | 529 | 0.090 |
Why?
| | Blood Glucose | 1 | 2023 | 2359 | 0.090 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2013 | 124 | 0.090 |
Why?
| | Papaverine | 1 | 2012 | 2 | 0.090 |
Why?
| | Sulfonamides | 2 | 2014 | 596 | 0.090 |
Why?
| | Renal Colic | 1 | 2012 | 4 | 0.090 |
Why?
| | Tadalafil | 1 | 2012 | 6 | 0.090 |
Why?
| | Aged, 80 and over | 2 | 2023 | 8430 | 0.090 |
Why?
| | Albuminuria | 1 | 2013 | 189 | 0.090 |
Why?
| | Placebos | 1 | 2012 | 193 | 0.090 |
Why?
| | Prazosin | 1 | 2011 | 25 | 0.080 |
Why?
| | Flank Pain | 1 | 2011 | 9 | 0.080 |
Why?
| | Urination Disorders | 1 | 2011 | 15 | 0.080 |
Why?
| | Isosorbide | 1 | 2011 | 1 | 0.080 |
Why?
| | Comorbidity | 1 | 2016 | 1672 | 0.080 |
Why?
| | Acute Pain | 1 | 2012 | 58 | 0.080 |
Why?
| | Otitis Media | 1 | 2013 | 185 | 0.080 |
Why?
| | Prone Position | 1 | 2010 | 25 | 0.080 |
Why?
| | Adult | 9 | 2023 | 41405 | 0.080 |
Why?
| | Weight Loss | 1 | 2016 | 867 | 0.080 |
Why?
| | Treatment Outcome | 6 | 2020 | 11947 | 0.080 |
Why?
| | Analgesics | 1 | 2012 | 231 | 0.080 |
Why?
| | Anthropometry | 1 | 2010 | 206 | 0.080 |
Why?
| | Institutionalization | 1 | 2009 | 12 | 0.080 |
Why?
| | Tooth Diseases | 1 | 2009 | 13 | 0.080 |
Why?
| | Mouth Diseases | 1 | 2009 | 48 | 0.070 |
Why?
| | Chronic Pain | 1 | 2013 | 301 | 0.070 |
Why?
| | Prognosis | 1 | 2016 | 4383 | 0.060 |
Why?
| | Stents | 1 | 2011 | 570 | 0.060 |
Why?
| | Pain Measurement | 3 | 2013 | 569 | 0.060 |
Why?
| | Neoplasms | 1 | 2020 | 2946 | 0.050 |
Why?
| | Chronic Disease | 3 | 2020 | 1844 | 0.050 |
Why?
| | Body Mass Index | 3 | 2019 | 2470 | 0.050 |
Why?
| | Kidney | 1 | 2010 | 1511 | 0.050 |
Why?
| | Dentistry | 1 | 2022 | 9 | 0.040 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 528 | 0.040 |
Why?
| | Postoperative Complications | 1 | 2014 | 3022 | 0.040 |
Why?
| | Cities | 1 | 2021 | 140 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2020 | 94 | 0.040 |
Why?
| | Bias | 1 | 2021 | 201 | 0.040 |
Why?
| | Survivors | 1 | 2024 | 528 | 0.040 |
Why?
| | Subcutaneous Fat | 1 | 2019 | 79 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2019 | 3660 | 0.040 |
Why?
| | Lipids | 1 | 2024 | 723 | 0.030 |
Why?
| | Drug Therapy, Combination | 2 | 2012 | 1046 | 0.030 |
Why?
| | Age Factors | 2 | 2019 | 3372 | 0.030 |
Why?
| | Cholesterol, LDL | 1 | 2019 | 363 | 0.030 |
Why?
| | Adolescent | 3 | 2014 | 22825 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2973 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2024 | 17560 | 0.030 |
Why?
| | Waist Circumference | 1 | 2016 | 146 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 6164 | 0.030 |
Why?
| | Ultrasonography | 1 | 2019 | 795 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2024 | 1431 | 0.030 |
Why?
| | Coronary Angiography | 1 | 2016 | 329 | 0.030 |
Why?
| | Premenopause | 1 | 2015 | 129 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1776 | 0.030 |
Why?
| | Varicocele | 1 | 2014 | 12 | 0.030 |
Why?
| | Scrotum | 1 | 2014 | 25 | 0.020 |
Why?
| | Herniorrhaphy | 1 | 2014 | 76 | 0.020 |
Why?
| | Operative Time | 1 | 2014 | 195 | 0.020 |
Why?
| | Postmenopause | 1 | 2015 | 394 | 0.020 |
Why?
| | Postoperative Period | 1 | 2013 | 351 | 0.020 |
Why?
| | Suppositories | 1 | 2012 | 3 | 0.020 |
Why?
| | Diclofenac | 1 | 2012 | 14 | 0.020 |
Why?
| | Hematuria | 1 | 2011 | 11 | 0.020 |
Why?
| | Nocturia | 1 | 2011 | 8 | 0.020 |
Why?
| | Placebo Effect | 1 | 2011 | 24 | 0.020 |
Why?
| | Time Factors | 2 | 2014 | 7173 | 0.020 |
Why?
| | Parasympatholytics | 1 | 2011 | 11 | 0.020 |
Why?
| | Celecoxib | 1 | 2011 | 42 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2012 | 430 | 0.020 |
Why?
| | Methylprednisolone | 1 | 2011 | 59 | 0.020 |
Why?
| | Odds Ratio | 1 | 2013 | 1084 | 0.020 |
Why?
| | Child | 1 | 2010 | 22979 | 0.020 |
Why?
| | Delayed-Action Preparations | 1 | 2011 | 191 | 0.020 |
Why?
| | Tongue, Fissured | 1 | 2009 | 1 | 0.020 |
Why?
| | Stomatitis, Denture | 1 | 2009 | 2 | 0.020 |
Why?
| | Burning Mouth Syndrome | 1 | 2009 | 5 | 0.020 |
Why?
| | Mouth Floor | 1 | 2009 | 7 | 0.020 |
Why?
| | Xerostomia | 1 | 2009 | 13 | 0.020 |
Why?
| | Mouth, Edentulous | 1 | 2009 | 10 | 0.020 |
Why?
| | Varicose Veins | 1 | 2009 | 16 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1550 | 0.020 |
Why?
| | Tongue | 1 | 2009 | 77 | 0.020 |
Why?
| | Periodontal Diseases | 1 | 2009 | 62 | 0.020 |
Why?
| | Atrophy | 1 | 2009 | 201 | 0.020 |
Why?
| | Acute Disease | 1 | 2012 | 1049 | 0.020 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 347 | 0.020 |
Why?
| | Dental Caries | 1 | 2009 | 173 | 0.020 |
Why?
| | Colon | 1 | 2010 | 310 | 0.020 |
Why?
| | Nursing Homes | 1 | 2009 | 174 | 0.020 |
Why?
| | Pyrazoles | 1 | 2011 | 518 | 0.020 |
Why?
| | Young Adult | 2 | 2014 | 14437 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2013 | 3027 | 0.010 |
Why?
| | Sex Factors | 1 | 2009 | 2136 | 0.010 |
Why?
| | Risk Assessment | 1 | 2013 | 3784 | 0.010 |
Why?
| | Prevalence | 1 | 2009 | 2889 | 0.010 |
Why?
|
|
Shakiba's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|